| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 4.71e-14 | 11 | 232 | 8 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 7.34e-11 | 32 | 232 | 9 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.06e-09 | 42 | 232 | 9 | GO:0098918 | |
| GeneOntologyMolecularFunction | channel activity | TRPM6 GABRG3 SCN11A KCNH8 TRPC6 GABRQ TMC3 CHRM5 KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G TOMM40 GRIN3A CACNA1E TMC2 HCN1 MPEG1 GRIK5 CALHM6 CACNA2D4 GSDMD | 2.62e-09 | 525 | 232 | 25 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPM6 GABRG3 SCN11A KCNH8 TRPC6 GABRQ TMC3 CHRM5 KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G TOMM40 GRIN3A CACNA1E TMC2 HCN1 MPEG1 GRIK5 CALHM6 CACNA2D4 GSDMD | 2.73e-09 | 526 | 232 | 25 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPM6 GABRG3 SCN11A KCNH8 TRPC6 GABRQ TMC3 CHRM5 KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G TOMM40 GRIN3A CACNA1E TMC2 HCN1 GRIK5 CALHM6 CACNA2D4 | 4.54e-09 | 459 | 232 | 23 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPM6 SCN11A KCNH8 TRPC6 KCNH6 KCNH1 SCN3A SCN7A CACNA1I CACNA1G TOMM40 GRIN3A CACNA1E TMC2 HCN1 GRIK5 CALHM6 CACNA2D4 | 1.17e-07 | 343 | 232 | 18 | GO:0005261 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | ACTBL2 ACTA1 ACTB ACTG1 POTEKP POTEE TUBA4B PLEC POTEF POTEJ POTEI | 3.55e-07 | 130 | 232 | 11 | GO:0005200 |
| GeneOntologyMolecularFunction | gated channel activity | GABRG3 KCNH8 GABRQ TMC3 CHRM5 KCNH6 CLCN1 KCNH1 SCN7A CACNA1I CACNA1G GRIN3A CACNA1E TMC2 HCN1 GRIK5 CACNA2D4 | 4.09e-07 | 334 | 232 | 17 | GO:0022836 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.37e-07 | 26 | 232 | 6 | GO:0005248 | |
| GeneOntologyMolecularFunction | transporter activity | TRPM6 GABRG3 SCN11A ABCC4 KCNH8 TRPC6 GABRQ ATP10B SLC35B2 TMC3 CHRM5 GRAMD1B KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G TOMM40 GRIN3A SLC38A3 CACNA1E TMC2 HCN1 TUSC3 SLC35A1 MPEG1 APOA4 GRIK5 CALHM6 CACNA2D4 GSDMD TMEM184C LRP6 LRP5 | 8.58e-07 | 1289 | 232 | 36 | GO:0005215 |
| GeneOntologyMolecularFunction | tripeptidyl-peptidase activity | 1.55e-06 | 3 | 232 | 3 | GO:0008240 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.24e-06 | 52 | 232 | 7 | GO:0005272 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TRPM6 GABRG3 SCN11A KCNH8 TRPC6 GABRQ TMC3 CHRM5 KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G TOMM40 GRIN3A SLC38A3 CACNA1E TMC2 HCN1 TUSC3 GRIK5 CALHM6 CACNA2D4 | 6.22e-06 | 793 | 232 | 25 | GO:0015075 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TRPM6 GABRG3 SCN11A ABCC4 KCNH8 TRPC6 GABRQ SLC35B2 TMC3 CHRM5 KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G TOMM40 GRIN3A SLC38A3 CACNA1E TMC2 HCN1 TUSC3 SLC35A1 MPEG1 GRIK5 CALHM6 CACNA2D4 GSDMD LRP6 LRP5 | 6.89e-06 | 1180 | 232 | 32 | GO:0022857 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPM6 SCN11A KCNH8 TRPC6 KCNH6 KCNH1 SCN3A SCN7A CACNA1I CACNA1G GRIN3A SLC38A3 CACNA1E TMC2 HCN1 TUSC3 GRIK5 CACNA2D4 | 9.04e-06 | 465 | 232 | 18 | GO:0046873 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | KCNH8 KCNH6 CLCN1 KCNH1 CACNA1I CACNA1G GRIN3A CACNA1E TMC2 HCN1 CACNA2D4 | 9.63e-06 | 182 | 232 | 11 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | KCNH8 KCNH6 CLCN1 KCNH1 CACNA1I CACNA1G GRIN3A CACNA1E TMC2 HCN1 CACNA2D4 | 1.07e-05 | 184 | 232 | 11 | GO:0022832 |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | PDE4B PDE6B PPP2R3B CHRM1 CHRM5 PTPN3 SYNJ1 PTPRO PDP2 PDE11A CASR PPEF2 PIKFYVE PPP2R5D NT5DC2 ENTPD3 | 1.25e-05 | 386 | 232 | 16 | GO:0042578 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TRPM6 GABRG3 SCN11A ABCC4 KCNH8 TRPC6 GABRQ CHRM5 KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G GRIN3A SLC38A3 CACNA1E TMC2 HCN1 TUSC3 GRIK5 CACNA2D4 | 2.72e-05 | 758 | 232 | 23 | GO:0015318 |
| GeneOntologyMolecularFunction | structural molecule activity | EPPK1 ACTBL2 ACTA1 ACTB OBSCN ACTG1 NUP62 POTEKP CHI3L1 NEB POTEE NID1 TUBA4B DMBT1 PLEC FLG POTEF KRT87P KRT23 TGM3 THBS1 POTEJ POTEI CTNND2 TNXB | 4.38e-05 | 891 | 232 | 25 | GO:0005198 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | KCNH8 KCNH6 KCNH1 CACNA1I CACNA1G CACNA1E TMC2 HCN1 CACNA2D4 | 7.35e-05 | 152 | 232 | 9 | GO:0022843 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TRPM6 SCN11A KCNH8 TRPC6 KCNH6 KCNH1 SCN3A SCN7A CACNA1I CACNA1G TOMM40 GRIN3A SLC38A3 CACNA1E TMC2 HCN1 TUSC3 GRIK5 CALHM6 CACNA2D4 | 1.02e-04 | 664 | 232 | 20 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium channel activity | 1.34e-04 | 129 | 232 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type II | 1.34e-04 | 2 | 232 | 2 | GO:0005026 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.89e-04 | 46 | 232 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | serine-type exopeptidase activity | 3.15e-04 | 12 | 232 | 3 | GO:0070008 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.93e-04 | 151 | 232 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 4.00e-04 | 3 | 232 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | threonine-tRNA ligase activity | 4.00e-04 | 3 | 232 | 2 | GO:0004829 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TRPM6 SCN11A KCNH8 TRPC6 KCNH6 KCNH1 SCN3A SCN7A CACNA1I CACNA1G GRIN3A SLC38A3 CACNA1E TMC2 HCN1 TUSC3 GRIK5 CACNA2D4 | 4.06e-04 | 627 | 232 | 18 | GO:0022890 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.62e-04 | 118 | 232 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 5.13e-04 | 14 | 232 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 6.26e-04 | 34 | 232 | 4 | GO:0017147 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 7.75e-04 | 16 | 232 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 8.93e-04 | 171 | 232 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 9.33e-04 | 17 | 232 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 9.45e-04 | 97 | 232 | 6 | GO:0008081 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.06e-03 | 39 | 232 | 4 | GO:0030551 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.11e-03 | 100 | 232 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.33e-03 | 70 | 232 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | protein kinase binding | NBEAL1 ACTBL2 ACTA2 ACTB ACTG1 POTEKP ACE ITGB3 SYNGAP1 POTEE KCNH1 KIF14 MAPRE2 IL31RA POTEF PPP1R9A CASR PPEF2 TGFBR2 POTEJ POTEI | 1.35e-03 | 873 | 232 | 21 | GO:0019901 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.76e-03 | 21 | 232 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.81e-03 | 75 | 232 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity | 1.96e-03 | 6 | 232 | 2 | GO:0043813 | |
| GeneOntologyMolecularFunction | fibrinogen binding | 1.96e-03 | 6 | 232 | 2 | GO:0070051 | |
| GeneOntologyMolecularFunction | phosphatase activity | PPP2R3B PTPN3 SYNJ1 PTPRO PDP2 PPEF2 PIKFYVE PPP2R5D NT5DC2 ENTPD3 | 2.01e-03 | 287 | 232 | 10 | GO:0016791 |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 2.03e-03 | 22 | 232 | 3 | GO:0004115 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.03e-03 | 77 | 232 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | kinase binding | NBEAL1 ACTBL2 KIF1B ACTA2 ACTB ACTG1 POTEKP ACE ITGB3 SYNGAP1 POTEE KCNH1 KIF14 MAPRE2 IL31RA POTEF PPP1R9A CASR PPEF2 TGFBR2 POTEJ POTEI | 2.14e-03 | 969 | 232 | 22 | GO:0019900 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX36 ABCC4 MYO5B KIF1B ACTB ACTC1 ATP10B ACSBG1 STARD9 KIF14 PMS1 DYNC2H1 RNF213 TOP6BL INO80 DNAH11 | 2.29e-03 | 614 | 232 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 2.62e-03 | 24 | 232 | 3 | GO:0047555 | |
| GeneOntologyMolecularFunction | G protein-coupled acetylcholine receptor activity | 2.72e-03 | 7 | 232 | 2 | GO:0016907 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 2.95e-03 | 25 | 232 | 3 | GO:0004114 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN14 CDH26 PPP2R3B LRP1B FSCB CEMIP2 EFCAB12 NID1 FER1L5 GPD2 FLG CACNA1E CASR PPEF2 LDLR TGM3 THBS1 GLCE | 2.98e-03 | 749 | 232 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 3.30e-03 | 26 | 232 | 3 | GO:0004435 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 3.69e-03 | 27 | 232 | 3 | GO:0004112 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 3.57e-11 | 31 | 229 | 9 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 1.20e-10 | 35 | 229 | 9 | GO:0099188 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | SCN11A NFASC CHRM5 CLCN1 SCN3A CACNA1I CACNA1G PLEC OTOA CACNA1E HCN1 | 4.88e-08 | 112 | 229 | 11 | GO:0019226 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | DHX36 SCN11A MYO5B SPR ACTBL2 TRPC6 ACTB ACTG1 NFASC EXT1 POTEKP CNTN6 SYNGAP1 POTEE PTPRO NKX6-1 PLXNB1 SEMA3F POTEF PPP1R9A ECE1 WDPCP IL1RAPL1 ROBO2 POTEJ POTEI CTNND2 | 7.64e-08 | 748 | 229 | 27 | GO:0048667 |
| GeneOntologyBiologicalProcess | postsynapse organization | DHX36 MYO5B ACTBL2 ACTB ACTG1 POTEKP ITGB3 SYNGAP1 POTEE SEMA3F POTEF PPP1R9A IL1RAPL1 LRP5 POTEJ POTEI CTNND2 | 8.60e-08 | 313 | 229 | 17 | GO:0099173 |
| GeneOntologyBiologicalProcess | cell junction organization | GABRG3 DHX36 CDH26 MYO5B ACTBL2 ACTB ACTG1 NFASC EXT1 POTEKP ACE ITGB3 CNTN6 SYNGAP1 POTEE PTPRO PLEC MAPRE2 PLXNB1 SEMA3F POTEF PPP1R9A WDPCP IL1RAPL1 THBS1 LRP5 ROBO2 POTEJ POTEI CTNND2 | 4.27e-07 | 974 | 229 | 30 | GO:0034330 |
| GeneOntologyBiologicalProcess | actin filament-based process | SCN11A PDE4B MYO5B ACTBL2 ACTA1 ACTA2 ACTB OBSCN ACTC1 ACTG1 POTEKP NEB ITGB3 SPTBN5 POTEE WASHC5 SVIL SCN3A SCN7A CACNA1G PLEC POTEF PPP1R9A ARHGAP17 POTEJ NOSTRIN POTEI TNXB | 1.14e-06 | 912 | 229 | 28 | GO:0030029 |
| GeneOntologyBiologicalProcess | cell morphogenesis | DHX36 SCN11A CDH26 MYO5B SPR ACTBL2 TRPC6 ACTB ACTG1 NFASC EXT1 POTEKP ITGB3 CNTN6 SYNGAP1 POTEE PTPRO NKX6-1 PLEC PHIP PLXNB1 SEMA3F POTEF PPP1R9A ECE1 PRPF40A WDPCP IL1RAPL1 LRP6 ROBO2 POTEJ POTEI CTNND2 | 1.21e-06 | 1194 | 229 | 33 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DHX36 SCN11A MYO5B ACTBL2 TRPC6 ACTB ACTG1 NFASC EXT1 POTEKP ITGB3 CNTN6 SYNGAP1 POTEE PTPRO NKX6-1 PLXNB1 SEMA3F POTEF PPP1R9A ECE1 IL1RAPL1 ROBO2 POTEJ POTEI CTNND2 | 1.81e-06 | 826 | 229 | 26 | GO:0048858 |
| GeneOntologyBiologicalProcess | synapse organization | GABRG3 DHX36 MYO5B ACTBL2 ACTB ACTG1 NFASC POTEKP ITGB3 CNTN6 SYNGAP1 POTEE PTPRO PLXNB1 SEMA3F POTEF PPP1R9A IL1RAPL1 LRP5 ROBO2 POTEJ POTEI CTNND2 | 2.56e-06 | 685 | 229 | 23 | GO:0050808 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DHX36 SCN11A MYO5B ACTBL2 TRPC6 ACTB ACTG1 NFASC EXT1 POTEKP CNTN6 SYNGAP1 POTEE PTPRO NKX6-1 PLXNB1 SEMA3F POTEF PPP1R9A ECE1 IL1RAPL1 ROBO2 POTEJ POTEI CTNND2 | 3.43e-06 | 802 | 229 | 25 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DHX36 SCN11A MYO5B ACTBL2 TRPC6 ACTB ACTG1 NFASC EXT1 POTEKP CNTN6 SYNGAP1 POTEE PTPRO NKX6-1 PLXNB1 SEMA3F POTEF PPP1R9A ECE1 IL1RAPL1 ROBO2 POTEJ POTEI CTNND2 | 4.95e-06 | 819 | 229 | 25 | GO:0120039 |
| GeneOntologyBiologicalProcess | neuron development | DHX36 SCN11A MBOAT1 MYO5B SPR ACTBL2 TRPC6 ACTB NAGLU ACTG1 NFASC EXT1 POTEKP CNTN6 SYNGAP1 POTEE PTPRO WASHC5 NKX6-1 GRIN3A PLXNB1 SEMA3F HCN1 POTEF PPP1R9A APOA4 ECE1 WDPCP IL1RAPL1 PPP2R5D LRP6 ROBO2 POTEJ POTEI CTNND2 TNXB | 5.47e-06 | 1463 | 229 | 36 | GO:0048666 |
| GeneOntologyBiologicalProcess | axonogenesis | SCN11A MYO5B ACTBL2 ACTB ACTG1 NFASC EXT1 POTEKP CNTN6 SYNGAP1 POTEE PTPRO NKX6-1 PLXNB1 SEMA3F POTEF ECE1 ROBO2 POTEJ POTEI | 5.62e-06 | 566 | 229 | 20 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | SCN11A MYO5B ACTBL2 ACTB ACTG1 NFASC EXT1 POTEKP CNTN6 SYNGAP1 POTEE PTPRO NKX6-1 PLXNB1 SEMA3F POTEF APOA4 ECE1 ROBO2 POTEJ POTEI | 1.06e-05 | 642 | 229 | 21 | GO:0061564 |
| GeneOntologyBiologicalProcess | mesenchyme migration | 1.33e-05 | 5 | 229 | 3 | GO:0090131 | |
| GeneOntologyBiologicalProcess | neuron projection development | DHX36 SCN11A MBOAT1 MYO5B ACTBL2 TRPC6 ACTB ACTG1 NFASC EXT1 POTEKP CNTN6 SYNGAP1 POTEE PTPRO WASHC5 NKX6-1 GRIN3A PLXNB1 SEMA3F POTEF PPP1R9A APOA4 ECE1 IL1RAPL1 PPP2R5D LRP6 ROBO2 POTEJ POTEI CTNND2 TNXB | 1.53e-05 | 1285 | 229 | 32 | GO:0031175 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 4.60e-05 | 36 | 229 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRG3 SCN11A KCNH8 GABRQ CHRM1 KCNH6 PTPN3 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G GRIN3A HCN1 PPP1R9A CASR GRIK5 | 5.65e-05 | 559 | 229 | 18 | GO:0042391 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO5B ACTBL2 ACTA1 ACTB OBSCN ACTC1 ACTG1 POTEKP NEB ITGB3 SPTBN5 POTEE WASHC5 SVIL PLEC POTEF PPP1R9A ARHGAP17 POTEJ NOSTRIN POTEI TNXB | 9.41e-05 | 803 | 229 | 22 | GO:0030036 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | TRPM6 GABRG3 SCN11A ABCC4 PDE4B KCNH8 TRPC6 GABRQ TMC3 ITGB3 KCNH6 PTPN3 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G GRIN3A CACNA1E TMC2 HCN1 TUSC3 CASR GRIK5 CALHM6 CACNA2D4 | 1.19e-04 | 1115 | 229 | 27 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway involved in heart development | 1.23e-04 | 2 | 229 | 2 | GO:0003307 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway involved in heart development | 1.23e-04 | 2 | 229 | 2 | GO:0003308 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | TRPM6 GABRG3 SCN11A ABCC4 PDE4B KCNH8 TRPC6 GABRQ ACE CHRM1 TMC3 ITGB3 KCNH6 PTPN3 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G TOMM40 GRIN3A SLC38A3 CACNA1E TMC2 HCN1 TUSC3 CASR GRIK5 CALHM6 CACNA2D4 | 1.32e-04 | 1374 | 229 | 31 | GO:0006811 |
| GeneOntologyBiologicalProcess | skeletal myofibril assembly | 2.09e-04 | 11 | 229 | 3 | GO:0014866 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 2.74e-04 | 52 | 229 | 5 | GO:0010799 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.18e-04 | 153 | 229 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 3.62e-04 | 156 | 229 | 8 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 3.62e-04 | 156 | 229 | 8 | GO:0010927 | |
| GeneOntologyBiologicalProcess | substance P catabolic process | 3.65e-04 | 3 | 229 | 2 | GO:0010814 | |
| GeneOntologyBiologicalProcess | threonyl-tRNA aminoacylation | 3.65e-04 | 3 | 229 | 2 | GO:0006435 | |
| GeneOntologyBiologicalProcess | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.65e-04 | 3 | 229 | 2 | GO:0002581 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 3.93e-04 | 86 | 229 | 6 | GO:0030239 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 4.17e-04 | 32 | 229 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | action potential | 4.27e-04 | 201 | 229 | 9 | GO:0001508 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.65e-09 | 32 | 231 | 8 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.65e-09 | 32 | 231 | 8 | GO:0043189 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRG3 SCN11A PDE4B KCNH8 TRPC6 GABRQ KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G GRIN3A CACNA1E HCN1 GRIK5 CACNA2D4 CATSPERB OLFM2 | 8.64e-09 | 378 | 231 | 20 | GO:0034702 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 2.99e-08 | 45 | 231 | 8 | GO:1902562 | |
| GeneOntologyCellularComponent | sodium channel complex | 6.55e-07 | 29 | 231 | 6 | GO:0034706 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 8.76e-07 | 17 | 231 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | transporter complex | GABRG3 SCN11A PDE4B KCNH8 TRPC6 GABRQ ATP10B KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G GRIN3A CACNA1E HCN1 GRIK5 CACNA2D4 CATSPERB OLFM2 | 8.93e-07 | 550 | 231 | 21 | GO:1990351 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRG3 SCN11A PDE4B KCNH8 TRPC6 GABRQ KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G GRIN3A CACNA1E HCN1 GRIK5 CACNA2D4 CATSPERB OLFM2 | 1.60e-06 | 523 | 231 | 20 | GO:1902495 |
| GeneOntologyCellularComponent | axon | DHX36 ZC3H14 SCN11A ACTBL2 KIF1B ACTB ACTG1 NFASC POTEKP CHRM1 CNTN6 POTEE SYNJ1 PTPRO KCNH1 SCN3A PLEC IL31RA HCN1 POTEF PPP1R9A CASR GRIK5 IL1RAPL1 ROBO2 POTEJ POTEI | 2.13e-06 | 891 | 231 | 27 | GO:0030424 |
| GeneOntologyCellularComponent | cation channel complex | SCN11A PDE4B TRPC6 KCNH1 SCN3A SCN7A CACNA1I CACNA1G CACNA1E HCN1 GRIK5 CACNA2D4 CATSPERB | 2.30e-06 | 235 | 231 | 13 | GO:0034703 |
| GeneOntologyCellularComponent | actin filament | ACTBL2 ACTA1 ACTB ACTC1 ACTG1 POTEKP POTEE POTEF POTEJ POTEI | 5.33e-06 | 146 | 231 | 10 | GO:0005884 |
| GeneOntologyCellularComponent | supramolecular fiber | PDE4B EPPK1 ACTBL2 KIF1B ACTA1 ACTA2 ACTB OBSCN ACTC1 ACTG1 POTEKP CMYA5 NEB KRTAP10-9 POTEE SYNJ1 SVIL KIF14 TUBA4B PLEC MAPRE2 TCHP DYNC2H1 POTEF INO80 KRT87P KRT23 LRPPRC POTEJ POTEI DNAH11 | 6.68e-06 | 1179 | 231 | 31 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | PDE4B EPPK1 ACTBL2 KIF1B ACTA1 ACTA2 ACTB OBSCN ACTC1 ACTG1 POTEKP CMYA5 NEB KRTAP10-9 POTEE SYNJ1 SVIL KIF14 TUBA4B PLEC MAPRE2 TCHP DYNC2H1 POTEF INO80 KRT87P KRT23 LRPPRC POTEJ POTEI DNAH11 | 7.64e-06 | 1187 | 231 | 31 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | EPPK1 ACTBL2 KIF1B ACTA1 ACTB ACTC1 ACTG1 POTEKP KRTAP10-9 POTEE SYNJ1 SVIL KIF14 TUBA4B PLEC MAPRE2 TCHP DYNC2H1 POTEF INO80 KRT87P KRT23 LRPPRC POTEJ POTEI DNAH11 | 7.66e-06 | 899 | 231 | 26 | GO:0099513 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 9.69e-06 | 94 | 231 | 8 | GO:0000123 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.10e-05 | 46 | 231 | 6 | GO:0005891 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.04e-05 | 104 | 231 | 8 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.87e-05 | 109 | 231 | 8 | GO:1902493 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 4.94e-05 | 19 | 231 | 4 | GO:0098871 | |
| GeneOntologyCellularComponent | costamere | 9.09e-05 | 22 | 231 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRG3 SCN11A GABRQ CHRM1 ITGB3 CHRM5 CNTN6 SYNJ1 PTPRO KCNH1 GRIN3A CACNA1E IL31RA HCN1 GRIK5 IL1RAPL1 ROBO2 OLFM2 | 9.10e-05 | 583 | 231 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRG3 DHX36 ZC3H14 SCN11A PDE4B MYO5B KIF1B NFASC CHRM1 CHRM5 SYNGAP1 PTPRO WASHC5 KCNH1 SCN3A CACNA1G GRIN3A PLEC PDE11A CACNA1E HCN1 PPP1R9A CASR GRIK5 LDLR IL1RAPL1 TP63 LRP6 CTNND2 | 9.45e-05 | 1228 | 231 | 29 | GO:0036477 |
| GeneOntologyCellularComponent | apical cortex | 1.51e-04 | 10 | 231 | 3 | GO:0045179 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.57e-04 | 73 | 231 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRG3 GABRQ CHRM1 ITGB3 CHRM5 PTPRO KCNH1 GRIN3A CACNA1E HCN1 GRIK5 IL1RAPL1 ROBO2 OLFM2 | 1.77e-04 | 405 | 231 | 14 | GO:0045211 |
| GeneOntologyCellularComponent | plasma membrane protein complex | SCN11A CDH26 PDE4B HLA-DOB ITGB3 SYNJ1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G GRIN3A CACNA1E HCN1 GRIK5 TGFBR2 CACNA2D4 LRP6 LRP5 CATSPERB OLFM2 | 1.78e-04 | 785 | 231 | 21 | GO:0098797 |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 1.79e-04 | 26 | 231 | 4 | GO:0099571 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SCN11A MYO5B ACTBL2 ACTB ACTC1 CHRM1 ITGB3 SYNGAP1 SYNJ1 PTPRO GRIN3A RAB4A SEMA3F HCN1 PPP1R9A CASR GRIK5 IL1RAPL1 ROBO2 OLFM2 CTNND2 | 3.04e-04 | 817 | 231 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.67e-04 | 157 | 231 | 8 | GO:0098839 | |
| GeneOntologyCellularComponent | membrane protein complex | GABRG3 SCN11A CDH26 PDE4B KCNH8 HLA-DOB TRPC6 GABRQ ITGB3 KCNH6 CLCN1 SYNJ1 KCNH1 SCN3A SCN7A CACNA1I CACNA1G TOMM40 GRIN3A CACNA1E HCN1 GOSR1 TUSC3 LAMP2 GRIK5 TGFBR2 CACNA2D4 LRP6 LRP5 CATSPERB OLFM2 | 5.48e-04 | 1498 | 231 | 31 | GO:0098796 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO5B ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 POTEKP NEB SPTBN5 POTEE SVIL POTEF PPP1R9A POTEJ POTEI | 7.10e-04 | 576 | 231 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | postsynapse | GABRG3 PDE4B MYO5B KIF1B ACTB ACTG1 GABRQ CHRM1 ITGB3 CHRM5 SYNGAP1 PTPRO KCNH1 GRIN3A RAB4A CACNA1E HCN1 PPP1R9A GRIK5 IL1RAPL1 ROBO2 OLFM2 CTNND2 | 9.45e-04 | 1018 | 231 | 23 | GO:0098794 |
| GeneOntologyCellularComponent | blood microparticle | 1.12e-03 | 144 | 231 | 7 | GO:0072562 | |
| GeneOntologyCellularComponent | Wnt-Frizzled-LRP5/6 complex | 1.19e-03 | 5 | 231 | 2 | GO:1990851 | |
| GeneOntologyCellularComponent | dendrite | GABRG3 DHX36 ZC3H14 PDE4B MYO5B KIF1B NFASC CHRM1 CHRM5 SYNGAP1 PTPRO KCNH1 CACNA1G PLEC HCN1 PPP1R9A GRIK5 IL1RAPL1 TP63 CTNND2 | 1.41e-03 | 858 | 231 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GABRG3 DHX36 ZC3H14 PDE4B MYO5B KIF1B NFASC CHRM1 CHRM5 SYNGAP1 PTPRO KCNH1 CACNA1G PLEC HCN1 PPP1R9A GRIK5 IL1RAPL1 TP63 CTNND2 | 1.45e-03 | 860 | 231 | 20 | GO:0097447 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.51e-03 | 290 | 231 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | platelet dense granule membrane | 1.77e-03 | 6 | 231 | 2 | GO:0031088 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.83e-03 | 201 | 231 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | dense body | 2.46e-03 | 7 | 231 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | apical part of cell | TRPM6 ABCC4 MYO5B ACTG1 ITGB3 SPTBN5 PTPRO PLEC SLC38A3 OTOA TCHP DYNC2H1 CASR LDLR WDPCP | 2.53e-03 | 592 | 231 | 15 | GO:0045177 |
| GeneOntologyCellularComponent | myofibril | 3.46e-03 | 273 | 231 | 9 | GO:0030016 | |
| Domain | Actin_CS | 4.14e-16 | 16 | 226 | 10 | IPR004001 | |
| Domain | ACTINS_2 | 9.96e-16 | 17 | 226 | 10 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.22e-15 | 18 | 226 | 10 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 4.63e-15 | 19 | 226 | 10 | PS01132 | |
| Domain | Actin | 1.96e-12 | 31 | 226 | 10 | IPR004000 | |
| Domain | Actin | 1.96e-12 | 31 | 226 | 10 | PF00022 | |
| Domain | ACTIN | 1.96e-12 | 31 | 226 | 10 | SM00268 | |
| Domain | ACTINS_1 | 8.06e-11 | 8 | 226 | 6 | PS00406 | |
| Domain | LY | 1.34e-08 | 15 | 226 | 6 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.34e-08 | 15 | 226 | 6 | IPR000033 | |
| Domain | Ion_trans_dom | TRPM6 SCN11A KCNH8 TRPC6 KCNH6 KCNH1 SCN3A SCN7A CACNA1I CACNA1G CACNA1E HCN1 | 1.37e-08 | 114 | 226 | 12 | IPR005821 |
| Domain | Ion_trans | TRPM6 SCN11A KCNH8 TRPC6 KCNH6 KCNH1 SCN3A SCN7A CACNA1I CACNA1G CACNA1E HCN1 | 1.37e-08 | 114 | 226 | 12 | PF00520 |
| Domain | Ldl_recept_b | 4.55e-07 | 14 | 226 | 5 | PF00058 | |
| Domain | LDLRB | 4.55e-07 | 14 | 226 | 5 | PS51120 | |
| Domain | - | 6.86e-06 | 39 | 226 | 6 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.84e-05 | 46 | 226 | 6 | IPR011042 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 1.90e-05 | 14 | 226 | 4 | IPR003938 | |
| Domain | Channel_four-helix_dom | 6.37e-05 | 57 | 226 | 6 | IPR027359 | |
| Domain | - | 6.37e-05 | 57 | 226 | 6 | 1.20.120.350 | |
| Domain | LRP5/6 | 1.46e-04 | 2 | 226 | 2 | IPR017049 | |
| Domain | fn3 | 1.62e-04 | 162 | 226 | 9 | PF00041 | |
| Domain | Na_channel_asu | 1.97e-04 | 10 | 226 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 1.97e-04 | 10 | 226 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.97e-04 | 10 | 226 | 3 | PF06512 | |
| Domain | PAS_9 | 1.97e-04 | 10 | 226 | 3 | PF13426 | |
| Domain | VDCCAlpha1 | 1.97e-04 | 10 | 226 | 3 | IPR002077 | |
| Domain | FN3 | 4.33e-04 | 185 | 226 | 9 | SM00060 | |
| Domain | ThrRS_core | 4.34e-04 | 3 | 226 | 2 | IPR033728 | |
| Domain | VDCC_T_a1 | 4.34e-04 | 3 | 226 | 2 | IPR005445 | |
| Domain | Thr-tRNA-ligase_IIa | 4.34e-04 | 3 | 226 | 2 | IPR002320 | |
| Domain | CNMP_BINDING_1 | 5.75e-04 | 32 | 226 | 4 | PS00888 | |
| Domain | CNMP_BINDING_2 | 5.75e-04 | 32 | 226 | 4 | PS00889 | |
| Domain | - | 5.77e-04 | 14 | 226 | 3 | 3.10.20.30 | |
| Domain | Beta-grasp_dom | 5.77e-04 | 14 | 226 | 3 | IPR012675 | |
| Domain | cNMP | 7.28e-04 | 34 | 226 | 4 | SM00100 | |
| Domain | cNMP_binding | 7.28e-04 | 34 | 226 | 4 | PF00027 | |
| Domain | FN3 | 7.32e-04 | 199 | 226 | 9 | PS50853 | |
| Domain | cNMP-bd_dom | 8.14e-04 | 35 | 226 | 4 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 8.14e-04 | 35 | 226 | 4 | PS50042 | |
| Domain | FN3_dom | 1.03e-03 | 209 | 226 | 9 | IPR003961 | |
| Domain | cNMP-bd-like | 1.12e-03 | 38 | 226 | 4 | IPR018490 | |
| Domain | LDLR_class-A_CS | 1.36e-03 | 40 | 226 | 4 | IPR023415 | |
| Domain | Musac_Ach_rcpt | 1.42e-03 | 5 | 226 | 2 | IPR000995 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.00e-07 | 31 | 180 | 7 | M877 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | SCN11A ACTB ACTG1 NFASC ITGB3 CNTN6 SPTBN5 SCN3A SCN7A TUBA4B | 3.34e-06 | 121 | 180 | 10 | M872 |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 2.77e-05 | 47 | 180 | 6 | M39829 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 1.15e-04 | 38 | 180 | 5 | M39549 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 2.38e-14 | 15 | 235 | 8 | 16824795 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 8.05e-11 | 6 | 235 | 5 | 22989508 | |
| Pubmed | 8.05e-11 | 6 | 235 | 5 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 8.05e-11 | 6 | 235 | 5 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 8.05e-11 | 6 | 235 | 5 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 8.05e-11 | 6 | 235 | 5 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 8.05e-11 | 6 | 235 | 5 | 8661406 | |
| Pubmed | 8.05e-11 | 6 | 235 | 5 | 23017337 | ||
| Pubmed | 8.05e-11 | 6 | 235 | 5 | 9841925 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 8.05e-11 | 6 | 235 | 5 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 8.05e-11 | 6 | 235 | 5 | 10074138 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 8.05e-11 | 6 | 235 | 5 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 8.05e-11 | 6 | 235 | 5 | 11709093 | |
| Pubmed | 8.05e-11 | 6 | 235 | 5 | 10049817 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 8.05e-11 | 6 | 235 | 5 | 23875777 | |
| Pubmed | 2.80e-10 | 7 | 235 | 5 | 22535526 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 2.80e-10 | 7 | 235 | 5 | 17504171 | |
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 2.80e-10 | 7 | 235 | 5 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 2.80e-10 | 7 | 235 | 5 | 22640593 | |
| Pubmed | 2.80e-10 | 7 | 235 | 5 | 22465675 | ||
| Pubmed | TPP2 STAM2 MYO5B BCAS2 ACTBL2 ACTA1 ACTB NAGLU PPP2R3B ACTG1 CEMIP2 PTPN3 RINT1 WASHC5 SVIL KIF14 PDP2 MAPRE2 PMS1 GPD2 PPP1R9A RNF213 PPEF2 PACS1 PPP2R5D FANCI LTN1 LRP6 | 7.35e-10 | 1049 | 235 | 28 | 27880917 | |
| Pubmed | 7.43e-10 | 8 | 235 | 5 | 20147394 | ||
| Pubmed | 7.43e-10 | 8 | 235 | 5 | 23260110 | ||
| Pubmed | 7.43e-10 | 8 | 235 | 5 | 14694110 | ||
| Pubmed | 1.11e-09 | 96 | 235 | 10 | 23580065 | ||
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 1.66e-09 | 9 | 235 | 5 | 10556093 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 1.66e-09 | 9 | 235 | 5 | 8892894 | |
| Pubmed | 1.66e-09 | 9 | 235 | 5 | 18775311 | ||
| Pubmed | 3.31e-09 | 10 | 235 | 5 | 1907279 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 3.31e-09 | 10 | 235 | 5 | 1991513 | |
| Pubmed | 3.31e-09 | 10 | 235 | 5 | 23575248 | ||
| Pubmed | 6.03e-09 | 11 | 235 | 5 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 6.03e-09 | 11 | 235 | 5 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 6.03e-09 | 11 | 235 | 5 | 19639585 | |
| Pubmed | 1.03e-08 | 12 | 235 | 5 | 23071112 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | DHX36 ABCC4 NAGLU EXT1 SLC35B2 LRP1B DDB1 CEMIP2 GRAMD1B RINT1 SVIL TMEM131L NID1 PLXNB1 SEMA3F GOSR1 SLC35A1 CHSY1 RNF213 LAMP2 ECE1 LDLR THBS1 FANCI GLCE LTN1 LRP6 LRP5 | 1.39e-08 | 1201 | 235 | 28 | 35696571 |
| Pubmed | 2.57e-08 | 14 | 235 | 5 | 21923909 | ||
| Pubmed | 2.57e-08 | 14 | 235 | 5 | 17411366 | ||
| Pubmed | 2.81e-08 | 100 | 235 | 9 | 21800051 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | SCN11A KCNH8 KCNH6 CLCN1 KCNH1 SCN3A SCN7A CACNA1G CACNA1E HCN1 | 4.08e-08 | 139 | 235 | 10 | 16985003 |
| Pubmed | 7.82e-08 | 17 | 235 | 5 | 17360745 | ||
| Pubmed | 7.82e-08 | 17 | 235 | 5 | 8997639 | ||
| Pubmed | Mapping of five subtype genes for muscarinic acetylcholine receptor to mouse chromosomes. | 7.82e-08 | 17 | 235 | 5 | 10549128 | |
| Pubmed | 7.88e-08 | 149 | 235 | 10 | 22664934 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 POTEKP POTEE TUBA4B TARS1 POTEF LAMP2 POTEJ POTEI | 9.77e-08 | 288 | 235 | 13 | 31501420 |
| Pubmed | 1.03e-07 | 56 | 235 | 7 | 37059927 | ||
| Pubmed | 1.08e-07 | 18 | 235 | 5 | 24840128 | ||
| Pubmed | SMG1 SCN11A MYO5B ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ATP10B NUP62 NEB POTEE RINT1 ZBED4 STARD9 EFCAB12 PLEC FLG CACNA1E POTEF PPP1R9A ECE1 KRT23 LRPPRC TMEM184C POTEJ NOSTRIN POTEI | 1.77e-07 | 1442 | 235 | 29 | 35575683 | |
| Pubmed | 2.49e-07 | 9 | 235 | 4 | 16364570 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 2.51e-07 | 21 | 235 | 5 | 21337463 | |
| Pubmed | ZNF559 OBSCN NEB SPTBN5 KCNH1 PLEC RNF213 ECE1 THBS1 FANCI LRP5 | 2.65e-07 | 214 | 235 | 11 | 22199357 | |
| Pubmed | Actin and myosin genes are transcriptionally regulated during mouse skeletal muscle development. | 3.05e-07 | 3 | 235 | 3 | 1728592 | |
| Pubmed | Restricted morphological and behavioral abnormalities following ablation of β-actin in the brain. | 3.05e-07 | 3 | 235 | 3 | 22403730 | |
| Pubmed | Overestimation of genetic risks owing to small sample sizes in cardiovascular studies. | 3.05e-07 | 3 | 235 | 3 | 12791034 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 3.05e-07 | 3 | 235 | 3 | 7780165 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 6865942 | ||
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 3842206 | ||
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 6641707 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 3.05e-07 | 3 | 235 | 3 | 17101985 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 3084797 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 3.24e-07 | 22 | 235 | 5 | 16526095 | |
| Pubmed | EPPK1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG1 NUP62 CMYA5 NEB TPP1 KIF14 TUBA4B PLEC TARS1 RNF213 FASTKD2 TGM3 LRPPRC NT5DC2 IAH1 CTNND2 | 3.51e-07 | 844 | 235 | 21 | 25963833 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 POTEKP POTEE PLEC POTEF POTEJ POTEI | 3.76e-07 | 271 | 235 | 12 | 32433965 |
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 4.11e-07 | 23 | 235 | 5 | 22004035 | |
| Pubmed | DHX36 SMG1 NFASC CEMIP2 MAST4 ACSBG1 WASHC5 TMEM131L CACNA1G PLXNB1 CHSY1 FASTKD2 INO80 CWC22 INTS5 ROBO2 | 7.58e-07 | 529 | 235 | 16 | 14621295 | |
| Pubmed | 7.91e-07 | 26 | 235 | 5 | 24742657 | ||
| Pubmed | ZC3H14 CYP24A1 TRPC6 CMYA5 CNTN6 STARD9 FLG RANBP10 PDZD9 HCN1 SLC35G2 ST6GALNAC2 THBS1 TIGD2 TMEM184C PLD5 NOSTRIN ALPK2 | 1.18e-06 | 686 | 235 | 18 | 29987050 | |
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 11812134 | ||
| Pubmed | The formin-homology-domain-containing protein FHOD1 enhances cell migration. | 1.21e-06 | 4 | 235 | 3 | 12665555 | |
| Pubmed | The proline-rich domain of tau plays a role in interactions with actin. | 1.21e-06 | 4 | 235 | 3 | 19895707 | |
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 26147384 | ||
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 2201580 | ||
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 1.49e-06 | 118 | 235 | 8 | 37105989 | |
| Pubmed | 1.76e-06 | 54 | 235 | 6 | 22266860 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | ACTBL2 KIF1B ACTB PPP2R3B ACTC1 ATP10B DDB1 PTPN3 PTPRO PPP1R9A ECH1 LRPPRC INTS5 PPP2R5D FANCI POTEI | 2.13e-06 | 573 | 235 | 16 | 28330616 |
| Pubmed | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 POTEKP SSBP1 NEB POTEE STARD9 NID1 POTEF THBS1 ALPK2 | 2.56e-06 | 513 | 235 | 15 | 25798074 | |
| Pubmed | 3.02e-06 | 5 | 235 | 3 | 19672307 | ||
| Pubmed | HIV-1 Tat protein inhibits neurosecretion by binding to phosphatidylinositol 4,5-bisphosphate. | 3.02e-06 | 5 | 235 | 3 | 23178941 | |
| Pubmed | 3.02e-06 | 5 | 235 | 3 | 9449696 | ||
| Pubmed | Microtubule associated protein MAP1A is an actin-binding and crosslinking protein. | 3.02e-06 | 5 | 235 | 3 | 7820861 | |
| Pubmed | D186/D190 is an allele-dependent determinant of HIV-1 Nef function. | 3.02e-06 | 5 | 235 | 3 | 27560372 | |
| Pubmed | Proteomic analysis reveals novel binding partners of MIP-T3 in human cells. | 3.20e-06 | 34 | 235 | 5 | 20391533 | |
| Pubmed | DHX36 BCAS2 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 POTEKP SSBP1 DDB1 POTEE SCN3A PDP2 TUBA4B RAB4A ADGRD1 POTEF ZNF12 TGM3 LRPPRC POTEJ POTEI | 4.13e-06 | 1153 | 235 | 23 | 29845934 | |
| Pubmed | TPP2 DHX36 MYO5B ACTBL2 KIF1B ACTA1 ACTB ACTG1 NFASC DDB1 SYNGAP1 GRAMD1B SYNJ1 WASHC5 SVIL PLEC TARS1 GPD2 PPP1R9A PRPF40A PACS1 LRPPRC TARS3 TRAPPC10 CTNND2 DNAH11 | 5.10e-06 | 1431 | 235 | 26 | 37142655 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX36 ZC3H14 EPPK1 MYO5B BCAS2 ACTBL2 ACTB ACTC1 NUP62 SSBP1 F5 DDB1 PTPN3 SVIL KIF14 TOMM40 PLEC TARS1 SLU7 CWC22 DNAJC2 TGM3 LRPPRC THBS1 | 5.29e-06 | 1257 | 235 | 24 | 36526897 |
| Pubmed | Connection between genetically determined blood coagulation factors and haemorheology. | 6.00e-06 | 6 | 235 | 3 | 18503143 | |
| Pubmed | 6.00e-06 | 6 | 235 | 3 | 20162297 | ||
| Pubmed | 6.00e-06 | 6 | 235 | 3 | 11568114 | ||
| Pubmed | 6.00e-06 | 6 | 235 | 3 | 19695239 | ||
| Pubmed | 6.00e-06 | 6 | 235 | 3 | 21080081 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KIF1B ACTG1 NUP62 SSBP1 ACE LRP1B DDB1 RINT1 MAST4 SYNJ1 WASHC5 SVIL KIF14 PLEC GOSR1 ECE1 ECH1 TGM3 PPP2R5D | 6.38e-06 | 853 | 235 | 19 | 28718761 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ZC3H14 EPPK1 MYO5B BCAS2 ACTBL2 ACTA1 ACTC1 ACTG1 NUP62 F5 DDB1 SVIL KIF14 PLEC PHIP TARS1 GPD2 TBC1D15 PPP1R9A PRPF40A LRPPRC | 7.28e-06 | 1024 | 235 | 21 | 24711643 |
| Pubmed | PDE4B NFASC SYNGAP1 SYNJ1 HCN1 PPP1R9A CHSY1 GRIK5 LRPPRC CTNND2 | 9.04e-06 | 251 | 235 | 10 | 27507650 | |
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 1.04e-05 | 7 | 235 | 3 | 9384381 | |
| Pubmed | 1.04e-05 | 7 | 235 | 3 | 30289203 | ||
| Pubmed | 1.05e-05 | 43 | 235 | 5 | 20876399 | ||
| Pubmed | Serum response factor is required for sprouting angiogenesis and vascular integrity. | 1.05e-05 | 43 | 235 | 5 | 18804439 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 POTEKP POTEE POTEF LRPPRC | 1.07e-05 | 256 | 235 | 10 | 24189400 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CEL SPR ACTA1 ACTA2 ACTB NAGLU ACTC1 ACTG1 POTEKP CHI3L1 ACE POTEE TPP1 NID1 POTEF LAMP2 APOA4 THBS1 POTEJ POTEI TNXB | 1.40e-05 | 1070 | 235 | 21 | 23533145 |
| Pubmed | 1.66e-05 | 8 | 235 | 3 | 28330839 | ||
| Interaction | ACTG2 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 NEB POTEE PLEC POTEF POTEJ POTEI ALPK2 | 6.84e-15 | 49 | 229 | 13 | int:ACTG2 |
| Interaction | CAP2 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 POTEF FASTKD2 PRPF40A POTEJ POTEI | 1.99e-10 | 66 | 229 | 11 | int:CAP2 |
| Interaction | POTEJ interactions | 3.07e-10 | 52 | 229 | 10 | int:POTEJ | |
| Interaction | PFN3 interactions | 4.36e-08 | 10 | 229 | 5 | int:PFN3 | |
| Interaction | LRRC20 interactions | 4.83e-08 | 19 | 229 | 6 | int:LRRC20 | |
| Interaction | WASH8P interactions | 7.93e-08 | 11 | 229 | 5 | int:WASH8P | |
| Interaction | ABRA interactions | 1.41e-07 | 36 | 229 | 7 | int:ABRA | |
| Interaction | SCIN interactions | 2.89e-07 | 58 | 229 | 8 | int:SCIN | |
| Interaction | POTEE interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 POTEE KIF14 FASTKD2 POTEJ POTEI | 3.87e-07 | 134 | 229 | 11 | int:POTEE |
| Interaction | GC interactions | 4.90e-07 | 62 | 229 | 8 | int:GC | |
| Interaction | NAA80 interactions | 4.96e-07 | 15 | 229 | 5 | int:NAA80 | |
| Interaction | DNASE1 interactions | 5.53e-07 | 7 | 229 | 4 | int:DNASE1 | |
| Interaction | PHACTR2 interactions | 7.70e-07 | 29 | 229 | 6 | int:PHACTR2 | |
| Interaction | POTEI interactions | 3.15e-06 | 105 | 229 | 9 | int:POTEI | |
| Interaction | ERRFI1 interactions | 3.69e-06 | 107 | 229 | 9 | int:ERRFI1 | |
| Interaction | FGD4 interactions | 8.00e-06 | 64 | 229 | 7 | int:FGD4 | |
| Interaction | RNASE3 interactions | 1.49e-05 | 14 | 229 | 4 | int:RNASE3 | |
| Interaction | NPB interactions | 1.72e-05 | 29 | 229 | 5 | int:NPB | |
| Interaction | PDCL3 interactions | 1.86e-05 | 100 | 229 | 8 | int:PDCL3 | |
| Interaction | FBXO40 interactions | 2.01e-05 | 15 | 229 | 4 | int:FBXO40 | |
| Interaction | GSN interactions | PDE4B ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 KIF14 UBE2Q2 POTEF POTEI | 3.25e-05 | 212 | 229 | 11 | int:GSN |
| Interaction | REG3A interactions | 3.44e-05 | 17 | 229 | 4 | int:REG3A | |
| Interaction | TMSB4X interactions | 3.51e-05 | 80 | 229 | 7 | int:TMSB4X | |
| Interaction | MRTFB interactions | 4.51e-05 | 57 | 229 | 6 | int:MRTFB | |
| Interaction | MAP1A interactions | 5.79e-05 | 117 | 229 | 8 | int:MAP1A | |
| Interaction | WASHC2A interactions | 7.79e-05 | 122 | 229 | 8 | int:WASHC2A | |
| Interaction | NEXN interactions | 8.04e-05 | 91 | 229 | 7 | int:NEXN | |
| Interaction | PXK interactions | 9.74e-05 | 41 | 229 | 5 | int:PXK | |
| Interaction | WASHC1 interactions | 9.88e-05 | 94 | 229 | 7 | int:WASHC1 | |
| Interaction | RNF217 interactions | 1.16e-04 | 9 | 229 | 3 | int:RNF217 | |
| Interaction | TWF2 interactions | 1.46e-04 | 100 | 229 | 7 | int:TWF2 | |
| Interaction | LRTM2 interactions | 1.64e-04 | 10 | 229 | 3 | int:LRTM2 | |
| Interaction | ANGPTL8 interactions | 1.64e-04 | 10 | 229 | 3 | int:ANGPTL8 | |
| Interaction | OPRL1 interactions | 1.65e-04 | 102 | 229 | 7 | int:OPRL1 | |
| Interaction | VIL1 interactions | 1.70e-04 | 25 | 229 | 4 | int:VIL1 | |
| Cytoband | 2q21.1 | 1.24e-05 | 58 | 235 | 5 | 2q21.1 | |
| GeneFamily | Actins | 4.25e-10 | 6 | 171 | 5 | 929 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 8.64e-08 | 13 | 171 | 5 | 685 | |
| GeneFamily | Low density lipoprotein receptors | 5.17e-06 | 13 | 171 | 4 | 634 | |
| GeneFamily | Fibronectin type III domain containing | 2.18e-05 | 160 | 171 | 9 | 555 | |
| GeneFamily | Calcium voltage-gated channel subunits | 9.82e-05 | 26 | 171 | 4 | 253 | |
| GeneFamily | Type 2 receptor serine/threonine kinases | 8.73e-04 | 5 | 171 | 2 | 346 | |
| GeneFamily | Cholinergic receptors muscarinic | 8.73e-04 | 5 | 171 | 2 | 180 | |
| GeneFamily | Zinc fingers BED-type|Pseudoautosomal region 1 | 1.30e-03 | 6 | 171 | 2 | 64 | |
| GeneFamily | Phosphodiesterases | 1.45e-03 | 24 | 171 | 3 | 681 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.40e-03 | 8 | 171 | 2 | 939 | |
| GeneFamily | Transmembrane channel likes | 2.40e-03 | 8 | 171 | 2 | 1135 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.06e-03 | 9 | 171 | 2 | 1203 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.32e-03 | 161 | 171 | 6 | 593 | |
| GeneFamily | EF-hand domain containing | 4.89e-03 | 219 | 171 | 7 | 863 | |
| Coexpression | GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN | SLC35B2 SYNJ1 PTPRO PLEC MAPRE2 ARHGAP17 CALHM6 CWC22 DNAJC2 ORMDL2 NOSTRIN | 2.01e-06 | 200 | 234 | 11 | M8054 |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | TRPM6 GABRG3 MYO5B ACTA2 ATP10B CMYA5 FREM1 PTPN3 CACNA1I IL31RA TP63 ROBO2 | 2.21e-06 | 244 | 234 | 12 | M40312 |
| Coexpression | CROMER_METASTASIS_DN | 5.84e-06 | 77 | 234 | 7 | M8417 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ACTBL2 NEB F5 LRP1B CNTN6 DMBT1 PDE11A TMC2 TOP6BL TGM3 ROS1 | 1.12e-09 | 162 | 235 | 11 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | OBSCN ACTC1 CMYA5 STAT4 MAST4 SVIL MAPRE2 CACNA1E IL1RAPL1 CTNND2 ALPK2 | 6.31e-09 | 191 | 235 | 11 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | OBSCN ACTC1 CMYA5 MAST4 SVIL MAPRE2 ENOX1 PPP1R9A WDPCP CTNND2 ALPK2 | 7.04e-09 | 193 | 235 | 11 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.61e-08 | 188 | 235 | 10 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | ACTA1 OBSCN ACTC1 CMYA5 GRAMD1B MAST4 SVIL PPP1R9A CTNND2 ALPK2 | 9.30e-08 | 195 | 235 | 10 | 75fc81bddb246dca3b437fb60827b1d4fe416405 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-07 | 169 | 235 | 9 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-07 | 179 | 235 | 9 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 5.60e-07 | 182 | 235 | 9 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 7.03e-07 | 187 | 235 | 9 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.68e-07 | 189 | 235 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.03e-07 | 190 | 235 | 9 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 9.55e-07 | 194 | 235 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 9.55e-07 | 194 | 235 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 145 | 235 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-MEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-06 | 200 | 235 | 9 | 53160551d558148d1d80ec87b90dd6be7d36e4c7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-MEC-MEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-06 | 200 | 235 | 9 | af4d922659b6f9d446797f7a3922a211e22f88e4 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 160 | 235 | 8 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.55e-06 | 163 | 235 | 8 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.67e-06 | 164 | 235 | 8 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-06 | 168 | 235 | 8 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-06 | 168 | 235 | 8 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.33e-06 | 169 | 235 | 8 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-06 | 172 | 235 | 8 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-06 | 172 | 235 | 8 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.31e-06 | 175 | 235 | 8 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-06 | 180 | 235 | 8 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-06 | 128 | 235 | 7 | 003e133469899a9abe3a7f6d7f580583b281f412 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.53e-06 | 181 | 235 | 8 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 5.76e-06 | 182 | 235 | 8 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 184 | 235 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 184 | 235 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 184 | 235 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.49e-06 | 185 | 235 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-06 | 186 | 235 | 8 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-06 | 186 | 235 | 8 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.75e-06 | 186 | 235 | 8 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 187 | 235 | 8 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 7.02e-06 | 187 | 235 | 8 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 187 | 235 | 8 | 7beba2a5d5978f2ae7d8bde10815705cf2572211 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 187 | 235 | 8 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 187 | 235 | 8 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.02e-06 | 187 | 235 | 8 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.30e-06 | 188 | 235 | 8 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-06 | 189 | 235 | 8 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-06 | 189 | 235 | 8 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.59e-06 | 189 | 235 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.89e-06 | 190 | 235 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.89e-06 | 190 | 235 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.89e-06 | 190 | 235 | 8 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.89e-06 | 190 | 235 | 8 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-06 | 190 | 235 | 8 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.89e-06 | 190 | 235 | 8 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-06 | 190 | 235 | 8 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.89e-06 | 190 | 235 | 8 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.20e-06 | 191 | 235 | 8 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.20e-06 | 191 | 235 | 8 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.20e-06 | 191 | 235 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.20e-06 | 191 | 235 | 8 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Endothelial-C|World / shred on cell class and cell subclass (v4) | 8.20e-06 | 191 | 235 | 8 | bf203931f973098b79ec681d1dd0854419819e98 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-06 | 192 | 235 | 8 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-06 | 192 | 235 | 8 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 8.52e-06 | 192 | 235 | 8 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-06 | 192 | 235 | 8 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-06 | 193 | 235 | 8 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.85e-06 | 193 | 235 | 8 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.85e-06 | 193 | 235 | 8 | 2218833749576ba1a0fc95bd155c781e7e1163c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.85e-06 | 193 | 235 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 8.85e-06 | 193 | 235 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.85e-06 | 193 | 235 | 8 | b7c0b4dbbe11f86cff6371d3d12a6b772b938d78 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.85e-06 | 193 | 235 | 8 | e44d777f65b907f299cefd73296805ac4c92d383 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-06 | 194 | 235 | 8 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 9.18e-06 | 194 | 235 | 8 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-06 | 194 | 235 | 8 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.18e-06 | 194 | 235 | 8 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-06 | 195 | 235 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.53e-06 | 195 | 235 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 9.53e-06 | 195 | 235 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 9.53e-06 | 195 | 235 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-06 | 195 | 235 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.90e-06 | 196 | 235 | 8 | 34e79918a448f6c19b87e1b1ce13c012b24be1f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.90e-06 | 196 | 235 | 8 | 8f82e01ca50aa4cd6149547505b4474a02fad618 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.90e-06 | 196 | 235 | 8 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.90e-06 | 196 | 235 | 8 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-05 | 197 | 235 | 8 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-05 | 197 | 235 | 8 | 0f37afad46b94c748a149d9ee681472d7a3e6937 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-05 | 197 | 235 | 8 | 4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-05 | 197 | 235 | 8 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-05 | 197 | 235 | 8 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 1.03e-05 | 197 | 235 | 8 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.03e-05 | 197 | 235 | 8 | 2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 198 | 235 | 8 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-05 | 199 | 235 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 199 | 235 | 8 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.15e-05 | 200 | 235 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-05 | 200 | 235 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-05 | 200 | 235 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.15e-05 | 200 | 235 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-05 | 200 | 235 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-05 | 200 | 235 | 8 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-05 | 200 | 235 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| Drug | manidipine | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACE CACNA1I CACNA1G CACNA1E LDLR CACNA2D4 | 2.33e-10 | 95 | 231 | 12 | CID000004008 |
| Drug | Nsc687160 | 1.71e-08 | 18 | 231 | 6 | CID005459290 | |
| Drug | tolytoxin | 2.48e-08 | 19 | 231 | 6 | CID006440827 | |
| Drug | NSC312786 | 4.88e-08 | 21 | 231 | 6 | CID000329495 | |
| Drug | AC1L8NVR | 4.88e-08 | 21 | 231 | 6 | CID000384633 | |
| Drug | Rgds Peptide | 1.29e-07 | 106 | 231 | 10 | CID000107775 | |
| Drug | DE gel | GABRG3 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 GABRQ ENOX1 GRIK5 CACNA2D4 | 2.47e-07 | 143 | 231 | 11 | CID000008146 |
| Drug | procaine | GABRG3 GABRQ CHRM1 SCN3A SCN7A CACNA1I CACNA1G TUBA4B GRIN3A CACNA1E CACNA2D4 | 4.87e-07 | 153 | 231 | 11 | CID000004914 |
| Drug | azaspiracid | 4.95e-07 | 30 | 231 | 6 | CID006451158 | |
| Drug | AC1L1HS4 | 7.43e-07 | 32 | 231 | 6 | CID000004267 | |
| Drug | m2-19 | 1.07e-06 | 19 | 231 | 5 | CID000079129 | |
| Drug | beryllium fluoride | 1.07e-06 | 103 | 231 | 9 | CID000024589 | |
| Drug | N,N'-p-phenylenedimaleimide | 1.08e-06 | 34 | 231 | 6 | CID000076765 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 1.08e-06 | 34 | 231 | 6 | CID000001312 | |
| Drug | riluzole | GABRG3 GABRQ NFASC SCN3A SCN7A CACNA1I CACNA1G GRIN3A CACNA1E GRIK5 CACNA2D4 | 1.74e-06 | 174 | 231 | 11 | CID000005070 |
| Drug | Gadolinium | 1.83e-06 | 21 | 231 | 5 | ctd:D005682 | |
| Drug | plakin | 1.86e-06 | 82 | 231 | 8 | CID000018752 | |
| Drug | Epi Lovastatin | CEL ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 LRP1B KCNH6 GPD2 APOA4 LDLR THBS1 LRP6 LRP5 | 2.33e-06 | 341 | 231 | 15 | CID000003962 |
| Drug | Lanthanum | 2.35e-06 | 22 | 231 | 5 | ctd:D007811 | |
| Drug | HU-211 | 2.51e-06 | 114 | 231 | 9 | CID000107778 | |
| Drug | Aspidium | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 GK2 POLL ST6GALNAC2 TP63 GFM1 | 3.00e-06 | 184 | 231 | 11 | CID000000815 |
| Drug | bistheonellide A | 3.22e-06 | 11 | 231 | 4 | CID006441172 | |
| Drug | Viroisin | 3.22e-06 | 11 | 231 | 4 | CID000119538 | |
| Drug | epsilon-ATP | 3.42e-06 | 41 | 231 | 6 | CID000162262 | |
| Drug | genistein | GABRG3 ABCC4 PDE6B ACTBL2 CYP24A1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 GABRQ ACE ITGB3 PTPN3 CLCN1 CACNA1I CACNA1G TUBA4B PLEC PHIP CACNA1E HCN1 CHSY1 APOA4 ECE1 PIKFYVE THBS1 CACNA2D4 TP63 | 3.45e-06 | 1117 | 231 | 29 | CID005280961 |
| Drug | oryzalin | 3.45e-06 | 63 | 231 | 7 | CID000029393 | |
| Drug | AC1L22RD | 4.10e-06 | 91 | 231 | 8 | CID000065183 | |
| Drug | 2,5-dihydroxybenzoic acid | 4.27e-06 | 65 | 231 | 7 | CID000003469 | |
| Drug | CaCl2 | 4.58e-06 | 156 | 231 | 10 | CID000024854 | |
| Drug | BFDGE | 4.79e-06 | 12 | 231 | 4 | CID000091511 | |
| Drug | AC1L8FNU | 5.23e-06 | 44 | 231 | 6 | CID000425429 | |
| Drug | glutamate | TRPM6 GABRG3 ACTBL2 TRPC6 ACTA1 ACTA2 ACTB ACTC1 ACTG1 GABRQ NFASC CHI3L1 CHRM1 CLCN1 HPD CACNA1I CACNA1G GRIN3A PLEC SLC38A3 GPD2 CACNA1E HCN1 GRIK5 CACNA2D4 CABIN1 | 5.68e-06 | 962 | 231 | 26 | CID000000611 |
| Drug | Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | TRPM6 ACTA2 ATP10B EXT1 ACE SPTBN5 KCNH1 CACNA1G PDE11A CWH43 ST6GALNAC2 | 5.79e-06 | 197 | 231 | 11 | 3062_UP |
| Drug | chlorpromazine | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 NUP62 CHRM1 CHRM5 HPD CABIN1 | 5.79e-06 | 197 | 231 | 11 | CID000002726 |
| Drug | caged ATP | 7.04e-06 | 70 | 231 | 7 | CID000123806 | |
| Drug | U46619 | ACTBL2 ACTB ACTC1 ACTG1 ACE CHRM1 ITGB3 CACNA1I CACNA1G CACNA1E GOSR1 CACNA2D4 ENTPD3 | 7.55e-06 | 285 | 231 | 13 | CID000005618 |
| Drug | CID5288653 | 8.36e-06 | 28 | 231 | 5 | CID005288653 | |
| Drug | NpCaM | 8.78e-06 | 48 | 231 | 6 | CID000122259 | |
| Drug | AC1Q6LQU | 8.78e-06 | 48 | 231 | 6 | CID000072380 | |
| Drug | gabapentin | GABRG3 GABRQ SCN3A SCN7A CACNA1I CACNA1G GRIN3A CACNA1E GRIK5 CACNA2D4 | 9.31e-06 | 169 | 231 | 10 | CID000003446 |
| Drug | kabiramide C | 9.54e-06 | 14 | 231 | 4 | CID005288658 | |
| Drug | AC1LD8HW | 1.12e-05 | 75 | 231 | 7 | CID000644061 | |
| Drug | AC1L1BDQ | 1.14e-05 | 173 | 231 | 10 | CID000001394 | |
| Drug | NSC106399 | 1.26e-05 | 51 | 231 | 6 | CID000002887 | |
| Drug | pyraclofos | 1.28e-05 | 106 | 231 | 8 | CID000093460 | |
| Drug | SIRIUS | 1.33e-05 | 77 | 231 | 7 | CID000091750 | |
| Drug | AC1Q3ZOL | GABRG3 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 GABRQ CHRM1 CLCN1 GRIK5 CACNA2D4 | 1.40e-05 | 258 | 231 | 12 | CID000002376 |
| Drug | AC1L2DAI | TPP2 ABCC4 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 PTPRO KCNH1 LDLR TSHZ1 GFM1 | 1.50e-05 | 304 | 231 | 13 | CID000004984 |
| Drug | Gdrgdsp | 1.57e-05 | 109 | 231 | 8 | CID000115346 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | ACTA1 ACTA2 ACTB ACTC1 ACTG1 CHRM1 PTPN3 CACNA1I CACNA1G CACNA1E HCN1 PIKFYVE CACNA2D4 | 1.72e-05 | 308 | 231 | 13 | CID000001915 |
| Drug | candesartan cilexetil | 1.79e-05 | 145 | 231 | 9 | CID000002540 | |
| Drug | 3-methylhistidine | 1.96e-05 | 55 | 231 | 6 | CID000064969 | |
| Drug | ML-9 | 1.99e-05 | 147 | 231 | 9 | CID000004217 | |
| Drug | 3,4-dihydroquinazoline | 2.02e-05 | 6 | 231 | 3 | CID000583065 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | ACTBL2 TRPC6 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACE CHRM1 PTPN3 CACNA1I CACNA1G CACNA1E CASR PIKFYVE CACNA2D4 ENTPD3 CABIN1 | 2.19e-05 | 568 | 231 | 18 | CID000000806 |
| Drug | Zonisamide | 2.21e-05 | 17 | 231 | 4 | DB00909 | |
| Drug | dihydrocytochalasin B | 2.66e-05 | 58 | 231 | 6 | CID000003064 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | TRPM6 ABCC4 PDE4B KCNH8 PDE6B ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACE CHRM1 CACNA1I CACNA1G PDE11A CACNA1E HCN1 CACNA2D4 | 2.69e-05 | 577 | 231 | 18 | CID000000295 |
| Drug | MAPS | 2.69e-05 | 191 | 231 | 10 | CID000066161 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 2.75e-05 | 86 | 231 | 7 | CID000000805 | |
| Drug | protocatechuic acid | 2.97e-05 | 119 | 231 | 8 | CID000000072 | |
| Drug | AC1NSKFN | 3.00e-05 | 36 | 231 | 5 | CID005311324 | |
| Drug | AC1L1KMJ | MYO5B ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 CHRM1 ITGB3 SPTBN5 KCNH6 PTPN3 TUBA4B PLEC PIKFYVE NOSTRIN | 3.13e-05 | 476 | 231 | 16 | CID000030956 |
| Drug | nilvadipine | 3.24e-05 | 60 | 231 | 6 | CID000004494 | |
| Drug | C75; Up 200; 10uM; MCF7; HT_HG-U133A | 3.50e-05 | 197 | 231 | 10 | 6423_UP | |
| Drug | Hypertensin II | TRPM6 ACTBL2 TRPC6 ACTB ACTC1 ACTG1 ACE LRP1B ITGB3 PTPN3 AMHR2 PIKFYVE THBS1 CACNA2D4 CABIN1 | 3.55e-05 | 429 | 231 | 15 | CID000025476 |
| Drug | 5'IATR | 3.55e-05 | 19 | 231 | 4 | CID000074997 | |
| Drug | AC1NSKHI | 3.56e-05 | 61 | 231 | 6 | CID005311358 | |
| Drug | naphthalene | 3.76e-05 | 123 | 231 | 8 | CID000000931 | |
| Drug | AC1OAGFB | STAM2 ACTBL2 TRPC6 ACTA1 ACTA2 ACTB ACTC1 ACTG1 CHRM1 ITGB3 SPTBN5 PTPN3 SYNJ1 SCN3A SCN7A RAB4A PIKFYVE | 3.94e-05 | 539 | 231 | 17 | CID006857345 |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A | 3.98e-05 | 200 | 231 | 10 | 665_DN | |
| Drug | AC1L1KC5 | ACTBL2 TRPC6 ACTA1 ACTA2 ACTB ACTC1 ACTG1 CHRM1 PTPN3 CACNA1I CACNA1G CACNA1E CASR PIKFYVE CACNA2D4 ENTPD3 CABIN1 | 4.12e-05 | 541 | 231 | 17 | CID000005428 |
| Drug | C18:1n-7 | 4.26e-05 | 92 | 231 | 7 | CID000122325 | |
| Drug | ATP betaS | 4.30e-05 | 162 | 231 | 9 | CID005311341 | |
| Drug | wiskostatin | 4.47e-05 | 39 | 231 | 5 | CID000448668 | |
| Drug | AC1OAGGW | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 CHRM1 GOSR1 PIKFYVE IL1RAPL1 | 4.52e-05 | 203 | 231 | 10 | CID006857364 |
| Drug | pimozide | 4.73e-05 | 127 | 231 | 8 | CID000016362 | |
| Drug | D3273 | 4.89e-05 | 94 | 231 | 7 | CID005464587 | |
| Drug | AC1L1GXW | 4.89e-05 | 94 | 231 | 7 | CID000003891 | |
| Drug | nitroglycerin | 5.11e-05 | 206 | 231 | 10 | CID000004510 | |
| Drug | microcystin-LR | 5.29e-05 | 129 | 231 | 8 | CID000445433 | |
| Drug | NSC339663 | MYO5B ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 SVIL TUBA4B PLEC PIKFYVE | 5.29e-05 | 250 | 231 | 11 | CID000003892 |
| Drug | Mgamp-pnp | 5.40e-05 | 21 | 231 | 4 | CID005311323 | |
| Drug | AC1LADJ6 | 5.58e-05 | 130 | 231 | 8 | CID000486032 | |
| Drug | 5-IAF | 5.59e-05 | 66 | 231 | 6 | CID000123822 | |
| Drug | pyrene | 5.90e-05 | 131 | 231 | 8 | CID000031423 | |
| Drug | polyethylene glycol | ACTBL2 ACTB ACTC1 ACTG1 F5 KCNH1 TPP1 POLL GPD2 MPEG1 ECH1 TP63 | 5.92e-05 | 299 | 231 | 12 | CID000000174 |
| Drug | AC1L1DXE | KCNH8 ACTA1 ACTA2 ACTB ACTC1 ACTG1 CHRM1 CACNA1I CACNA1G CACNA1E PIKFYVE CACNA2D4 | 5.92e-05 | 299 | 231 | 12 | CID000002548 |
| Drug | NSC3096 | 6.39e-05 | 98 | 231 | 7 | CID000002832 | |
| Drug | AC1L1ERT | 7.19e-05 | 69 | 231 | 6 | CID000002920 | |
| Drug | cryptotanshinone | 7.24e-05 | 43 | 231 | 5 | CID000160254 | |
| Drug | N-ethylmaleimide | PDE4B MYO5B KIF1B ACTA1 ACTA2 ACTB ACTC1 ACTG1 CHRM1 SPTBN5 RINT1 GOSR1 SLC35A1 ENTPD3 NOSTRIN GFM1 | 7.26e-05 | 511 | 231 | 16 | CID000004362 |
| Drug | isradipine | 7.27e-05 | 100 | 231 | 7 | CID000003784 | |
| Drug | lanthanum | 7.68e-05 | 136 | 231 | 8 | CID000023926 | |
| Drug | pseudococaine | SCN11A ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 CHRM1 CHRM5 SCN3A SCN7A AMHR2 GRIK5 PIKFYVE IL1RAPL1 THBS1 CABIN1 | 7.83e-05 | 570 | 231 | 17 | CID000002826 |
| Drug | Strontium | 8.28e-05 | 9 | 231 | 3 | ctd:D013324 | |
| Drug | noradrealine | CEL SPR ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACE CHRM1 CACNA1I CACNA1G TUBA4B CACNA1E CASR PIKFYVE CACNA2D4 | 8.71e-05 | 575 | 231 | 17 | CID000000951 |
| Drug | Barium | 9.13e-05 | 72 | 231 | 6 | ctd:D001464 | |
| Drug | Nbd-Ph | 9.35e-05 | 24 | 231 | 4 | CID004682184 | |
| Drug | L-Carnosine | 9.87e-05 | 73 | 231 | 6 | CID000009369 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.09e-14 | 8 | 225 | 7 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.09e-14 | 8 | 225 | 7 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.09e-14 | 8 | 225 | 7 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.09e-14 | 8 | 225 | 7 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.61e-13 | 10 | 225 | 7 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.61e-13 | 10 | 225 | 7 | DOID:13832 (implicated_via_orthology) | |
| Disease | non-arteritic anterior ischemic optic neuropathy (is_implicated_in) | 4.33e-06 | 5 | 225 | 3 | DOID:0050864 (is_implicated_in) | |
| Disease | Schizophrenia | PDE4B MYO5B ACTB GABRQ NFASC CHI3L1 CMYA5 ACE CHRM1 ITGB3 CHRM5 SYNGAP1 KCNH6 TAAR1 GRIN3A APOA4 GRIK5 THBS1 CTNND2 TNXB | 1.60e-05 | 883 | 225 | 20 | C0036341 |
| Disease | nemaline myopathy (implicated_via_orthology) | 2.38e-05 | 8 | 225 | 3 | DOID:3191 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 3.50e-05 | 261 | 225 | 10 | C0004352 | |
| Disease | epilepsy (implicated_via_orthology) | 3.81e-05 | 163 | 225 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.05e-05 | 10 | 225 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.05e-05 | 10 | 225 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 5.79e-05 | 2 | 225 | 2 | C1855722 | |
| Disease | hepatitis (is_marker_for) | 5.79e-05 | 2 | 225 | 2 | DOID:2237 (is_marker_for) | |
| Disease | Baraitser-Winter syndrome | 5.79e-05 | 2 | 225 | 2 | cv:C1853623 | |
| Disease | Moyamoya disease 1 | 5.79e-05 | 2 | 225 | 2 | C2931384 | |
| Disease | chondrosarcoma (is_marker_for) | 5.79e-05 | 2 | 225 | 2 | DOID:3371 (is_marker_for) | |
| Disease | Fryns-Aftimos Syndrome | 5.79e-05 | 2 | 225 | 2 | C1853623 | |
| Disease | electrocardiography | PDE4B MBOAT1 ACTB OBSCN PTPN3 MAST4 SVIL CACNA1G PLEC MAPRE2 HCN1 POTEF WDPCP ROS1 | 6.28e-05 | 530 | 225 | 14 | EFO_0004327 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 9.15e-05 | 12 | 225 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Familial vesicoureteral reflux | 1.73e-04 | 3 | 225 | 2 | cv:C4706552 | |
| Disease | polymyositis (is_implicated_in) | 1.73e-04 | 3 | 225 | 2 | DOID:0080745 (is_implicated_in) | |
| Disease | Familial vesicoureteral reflux | 1.73e-04 | 3 | 225 | 2 | C4706552 | |
| Disease | dermatomyositis (is_implicated_in) | 1.73e-04 | 3 | 225 | 2 | DOID:10223 (is_implicated_in) | |
| Disease | Vesicoureteral reflux | 1.73e-04 | 3 | 225 | 2 | cv:C0042580 | |
| Disease | hypercalcemia (is_implicated_in) | 1.73e-04 | 3 | 225 | 2 | DOID:12678 (is_implicated_in) | |
| Disease | Intellectual Disability | ZC3H14 SPR NAGLU NUP62 SYNGAP1 TPP1 SCN3A CACNA1G PHIP CACNA1E PACS1 PPP2R5D | 1.81e-04 | 447 | 225 | 12 | C3714756 |
| Disease | coronary artery calcification | GABRG3 LRP1B PTPN3 STARD9 MAPRE2 ARMH3 SLC38A3 CACNA1E GRIK5 LDLR LRP6 PLD5 | 1.92e-04 | 450 | 225 | 12 | EFO_0004723 |
| Disease | Vesico-Ureteral Reflux | 3.44e-04 | 4 | 225 | 2 | C0042580 | |
| Disease | amino acid metabolic disorder (implicated_via_orthology) | 3.44e-04 | 4 | 225 | 2 | DOID:9252 (implicated_via_orthology) | |
| Disease | vesicoureteral reflux (is_implicated_in) | 5.70e-04 | 5 | 225 | 2 | DOID:9620 (is_implicated_in) | |
| Disease | Moyamoya disease (is_implicated_in) | 5.70e-04 | 5 | 225 | 2 | DOID:13099 (is_implicated_in) | |
| Disease | Kidney Failure | 6.05e-04 | 22 | 225 | 3 | C0035078 | |
| Disease | HMG CoA reductase inhibitor use measurement | 6.46e-04 | 189 | 225 | 7 | EFO_0009932 | |
| Disease | Coronary heart disease | 7.87e-04 | 24 | 225 | 3 | C0010068 | |
| Disease | Dyslipidemias | 7.87e-04 | 24 | 225 | 3 | C0242339 | |
| Disease | Dyslipoproteinemias | 7.87e-04 | 24 | 225 | 3 | C0598784 | |
| Disease | asthma, response to diisocyanate | 9.31e-04 | 261 | 225 | 8 | EFO_0006995, MONDO_0004979 | |
| Disease | urate measurement, bone density | TRPM6 MBOAT1 TRPC6 FREM1 GRAMD1B MAST4 KIF14 DMBT1 SLC38A3 CTNND2 CABIN1 TNXB DNAH11 | 1.01e-03 | 619 | 225 | 13 | EFO_0003923, EFO_0004531 |
| Disease | acute kidney failure (implicated_via_orthology) | 1.12e-03 | 27 | 225 | 3 | DOID:3021 (implicated_via_orthology) | |
| Disease | calcium measurement | TRPM6 ANKRD31 ABCC4 CYP24A1 LRP1B KIF14 DMBT1 PLEC FER1L5 CASR GRIK5 ECE1 NT5DC2 | 1.15e-03 | 628 | 225 | 13 | EFO_0004838 |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 1.15e-03 | 60 | 225 | 4 | EFO_0020690 | |
| Disease | complex trait | 1.18e-03 | 271 | 225 | 8 | EFO_0010578 | |
| Disease | Nemaline Myopathy, Childhood Onset | 1.19e-03 | 7 | 225 | 2 | C0546125 | |
| Disease | Aortic Aneurysm, Thoracoabdominal | 1.19e-03 | 7 | 225 | 2 | C0340630 | |
| Disease | Uveoretinal Coloboma | 1.19e-03 | 7 | 225 | 2 | C4554007 | |
| Disease | X-12244--N-acetylcarnosine measurement | 1.19e-03 | 7 | 225 | 2 | EFO_0021299 | |
| Disease | Aortic Aneurysm, Thoracic | 1.19e-03 | 7 | 225 | 2 | C0162872 | |
| Disease | blood N-acetylcarnosine measurement | 1.19e-03 | 7 | 225 | 2 | EFO_0022217 | |
| Disease | Osteoporosis, Age-Related | 1.22e-03 | 61 | 225 | 4 | C0001787 | |
| Disease | Post-Traumatic Osteoporosis | 1.22e-03 | 61 | 225 | 4 | C0751406 | |
| Disease | Osteoporosis, Senile | 1.22e-03 | 61 | 225 | 4 | C0029459 | |
| Disease | cerebral white matter volume change measurement, age at assessment | 1.24e-03 | 28 | 225 | 3 | EFO_0008007, EFO_0021499 | |
| Disease | memory performance | 1.26e-03 | 409 | 225 | 10 | EFO_0004874 | |
| Disease | Osteoporosis | 1.38e-03 | 63 | 225 | 4 | C0029456 | |
| Disease | cerebral infarction (is_implicated_in) | 1.38e-03 | 29 | 225 | 3 | DOID:3526 (is_implicated_in) | |
| Disease | Epilepsy | 1.51e-03 | 109 | 225 | 5 | C0014544 | |
| Disease | right ventricular ejection fraction measurement | 1.53e-03 | 30 | 225 | 3 | EFO_0021816 | |
| Disease | N-acetylcarnosine measurement | 1.57e-03 | 8 | 225 | 2 | EFO_0022101 | |
| Disease | Myopathies, Nemaline | 1.57e-03 | 8 | 225 | 2 | C0206157 | |
| Disease | Nemaline myopathy | 1.57e-03 | 8 | 225 | 2 | cv:C0206157 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.68e-03 | 31 | 225 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | risky sexual behaviour measurement | 1.94e-03 | 169 | 225 | 6 | EFO_0007877 | |
| Disease | hyperlipidemia | 2.01e-03 | 9 | 225 | 2 | MONDO_0021187 | |
| Disease | asparaginase-induced acute pancreatitis | 2.01e-03 | 9 | 225 | 2 | EFO_1001507 | |
| Disease | Congenital ocular coloboma (disorder) | 2.01e-03 | 9 | 225 | 2 | C0009363 | |
| Disease | nephrolithiasis | 2.02e-03 | 33 | 225 | 3 | EFO_0004253 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 2.04e-03 | 70 | 225 | 4 | EFO_0008082 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.14e-03 | 71 | 225 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | chronic lymphocytic leukemia | 2.23e-03 | 119 | 225 | 5 | EFO_0000095 | |
| Disease | lifestyle measurement | 2.26e-03 | 235 | 225 | 7 | EFO_0010724 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 2.49e-03 | 239 | 225 | 7 | EFO_0010934 | |
| Disease | lung cancer (is_implicated_in) | 2.50e-03 | 74 | 225 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | primary biliary cholangitis (is_implicated_in) | 2.50e-03 | 10 | 225 | 2 | DOID:12236 (is_implicated_in) | |
| Disease | quality of life during menstruation measurement, aggressive behavior | 2.50e-03 | 10 | 225 | 2 | EFO_0003015, EFO_0009366 | |
| Disease | membranoproliferative glomerulonephritis (implicated_via_orthology) | 2.50e-03 | 10 | 225 | 2 | DOID:2920 (implicated_via_orthology) | |
| Disease | Congenital neurologic anomalies | 2.50e-03 | 10 | 225 | 2 | C0497552 | |
| Disease | Cranioschisis | 2.50e-03 | 10 | 225 | 2 | C0265541 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.50e-03 | 10 | 225 | 2 | cv:C4707243 | |
| Disease | colon cancer (is_implicated_in) | 2.59e-03 | 36 | 225 | 3 | DOID:219 (is_implicated_in) | |
| Disease | angina pectoris | 2.76e-03 | 125 | 225 | 5 | EFO_0003913 | |
| Disease | Myopia | 2.94e-03 | 385 | 225 | 9 | HP_0000545 | |
| Disease | Systemic lupus erythematosus | 3.04e-03 | 11 | 225 | 2 | cv:C0024141 | |
| Disease | meningitis | 3.04e-03 | 11 | 225 | 2 | MONDO_0021108 | |
| Disease | verbal-numerical reasoning measurement | 3.37e-03 | 131 | 225 | 5 | EFO_0008394 | |
| Disease | susceptibility to shingles measurement | 3.46e-03 | 81 | 225 | 4 | EFO_0008401 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 3.51e-03 | 40 | 225 | 3 | EFO_0004746 | |
| Disease | free cholesterol in medium LDL measurement | 3.51e-03 | 40 | 225 | 3 | EFO_0022268 | |
| Disease | Epilepsy, Cryptogenic | 3.62e-03 | 82 | 225 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 3.62e-03 | 82 | 225 | 4 | C0751111 | |
| Disease | Aura | 3.62e-03 | 82 | 225 | 4 | C0236018 | |
| Disease | AL amyloidosis | 3.63e-03 | 12 | 225 | 2 | MONDO_0019438 | |
| Disease | level of Diacylglycerol (18:1_18:2) in blood serum | 3.63e-03 | 12 | 225 | 2 | OBA_2045171 | |
| Disease | alpha-hydroxybutyric acid measurement | 3.63e-03 | 12 | 225 | 2 | EFO_0010458 | |
| Disease | end stage renal disease (is_implicated_in) | 3.77e-03 | 41 | 225 | 3 | DOID:783 (is_implicated_in) | |
| Disease | lifestyle measurement, anxiety disorder measurement | 4.08e-03 | 137 | 225 | 5 | EFO_0007795, EFO_0010724 | |
| Disease | autoimmune hepatitis (is_implicated_in) | 4.27e-03 | 13 | 225 | 2 | DOID:2048 (is_implicated_in) | |
| Disease | intermediate coronary syndrome (is_marker_for) | 4.27e-03 | 13 | 225 | 2 | DOID:8805 (is_marker_for) | |
| Disease | Sicca Syndrome | 4.27e-03 | 13 | 225 | 2 | C0086981 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSNAWTYLVIINNMS | 206 | Q9NVA4 | |
| WSSAQGIESMLKYVE | 521 | Q9Y6F7 | |
| TSSWELLMEAYSLIQ | 866 | Q96N23 | |
| DTTWFNMTQTIYSQL | 221 | Q9H7T0 | |
| ITMEGWTTVLYNTND | 306 | Q15878 | |
| TNVMATSRKYEDLLW | 771 | P12821 | |
| LSTFQQMWITKQEYD | 351 | P68133 | |
| ELYTRDNSMTWEASF | 146 | Q6QNK2 | |
| STFQQMWISKQEYDE | 351 | Q562R1 | |
| MTDYSNAVWQRNLLG | 336 | Q86TB3 | |
| TFQQMWISKQEYDES | 351 | Q9BYX7 | |
| TFQQMWISKQEYDES | 351 | P60709 | |
| TFQQMWISKQEYDES | 351 | P63261 | |
| SEAWASSSLIAMPQY | 296 | P41180 | |
| TSMNVYSLSVDPNTW | 116 | P57764 | |
| NNYAVSTNWESKEMQ | 181 | Q49SQ1 | |
| LSTFQQMWISKQEYD | 351 | P62736 | |
| WLSTVYAGSNLAMQD | 531 | Q96SM3 | |
| ITEISQTWATMKFSY | 1461 | Q96DT5 | |
| WNNEYIMSLISDNAA | 426 | Q14738 | |
| YSMVLRLSTNAGQWK | 566 | Q5T2E6 | |
| WYSAMAQGQAISTLV | 441 | O94923 | |
| DYENTGRMTQKWIQS | 216 | P20930 | |
| QDRTVSKAMIAYWTN | 476 | P19835 | |
| AGTNSRWEVIANYMN | 471 | Q99543 | |
| VKAASQVLNSMWQYR | 1006 | Q9UQB3 | |
| NTITMDILANTYKQW | 251 | Q6NXP0 | |
| TYKQWSMAQQRSSLA | 261 | Q6NXP0 | |
| MLEYTTQTLTAWQGL | 651 | Q3KR37 | |
| NSECYNLSTFWISMV | 1186 | O94823 | |
| LTQYTSDWGSSLRMA | 291 | Q16671 | |
| SQEAAQKWTYTMREG | 341 | A8MX76 | |
| PSLQMNTSIWYNRSD | 521 | P54802 | |
| TKTAQMWYQQGFRSL | 346 | Q9UGP5 | |
| SIAWSLGYMLSLTNQ | 456 | O75355 | |
| AGYWDNSIQVMSLTK | 2416 | Q6ZS30 | |
| GEWQAVLQNMVSSYL | 251 | Q6VN20 | |
| MVDESGLWAVYTTNQ | 326 | O95897 | |
| YWLSEASTQRMLQDC | 21 | Q9Y5P8 | |
| MQAEYWSVSAKTGEN | 261 | O95755 | |
| YNALTNWLTDARMLA | 101 | P20338 | |
| STSWAYQEGILSMKV | 256 | Q52LD8 | |
| QEKNVLSQYWTMGSR | 316 | P26045 | |
| LSQYWTMGSRNTKKS | 321 | P26045 | |
| WQYMVLDEAQALKSS | 646 | Q9ULG1 | |
| MNSEILESWANYQSS | 96 | Q2M385 | |
| MLAWLETTSENQALY | 1251 | O94822 | |
| QVATVMWDYFSQLSN | 26 | P06727 | |
| WYIMQSIQSKYSLSE | 6 | Q9H765 | |
| SMQETQLSLETWNYS | 1481 | Q8N7Z5 | |
| LYSWMTGILQTSSNA | 231 | Q7RTW8 | |
| LYSVVMSQKVSNWLG | 131 | Q8N0Y5 | |
| SGRWDQQYVIQLTSM | 166 | Q9NVI1 | |
| TFQQMWISKQEYDES | 1051 | A5A3E0 | |
| WEQMDYGLQFTSSRK | 86 | Q53FV1 | |
| MNIVSSYADIQSWLE | 536 | Q15058 | |
| KWTTYRSMAEDTINA | 436 | P43304 | |
| MAAGTSSYWEDLRKQ | 1 | O95249 | |
| NDTIYWTDMGFNKIS | 1921 | Q9NZR2 | |
| LKMDRSQQTSRTGYW | 126 | Q5H9T9 | |
| ESFWVSMISYNSLGK | 296 | Q8NI17 | |
| DSVNWELSTTYFTMA | 961 | Q3B7T1 | |
| SFWMNYDSSAARVTI | 286 | Q9UN88 | |
| AIYVTMEILSNWGNS | 476 | O60303 | |
| TSLGQSMSKYDLLVW | 1241 | O60333 | |
| QRLYWTDLDTNMIES | 816 | O75197 | |
| AWSYTNGIDMNAVLK | 556 | Q9H252 | |
| ITDKNSLAYQRMSWE | 146 | Q9HCG8 | |
| WNDVTLYGMLNTLKN | 71 | P36222 | |
| NWYRMSPSNQTDKLA | 66 | Q15116 | |
| EMNSVLAELSWNYSG | 2066 | O43157 | |
| LAQSAGLSLMWYKSS | 66 | Q9NZN1 | |
| DDTYWKEINAAMALT | 301 | Q8IYA7 | |
| QSLTYSSRMSWGIQQ | 131 | P47883 | |
| MEKSSYSDWLINNSI | 461 | Q9HCR9 | |
| PYWIMVKQDNESSSS | 221 | Q8IXQ8 | |
| ILDTLEDNRNWYQSM | 641 | Q07343 | |
| LTQFLGWSVMNTDTY | 421 | P35913 | |
| TDWNRDNPKIETSYM | 1081 | P14543 | |
| SVAESLNYVASWNMS | 286 | Q13011 | |
| SSFTWKDLSDMQIAY | 356 | Q5H8C1 | |
| KTIRNNSWLYQLAMD | 411 | O95259 | |
| TWYKEQSAAMSQEAA | 261 | Q9C075 | |
| YWTDLDTNLIESSNM | 806 | O75581 | |
| WQMNFTVRYETTNKT | 46 | P13473 | |
| YQEVMNSKLAWTLRS | 221 | A6NCN2 | |
| SMNINLWSEITELLY | 551 | P42704 | |
| SAMTYAQLESLINKW | 326 | P37198 | |
| ATSIEKYDLRTNMWT | 481 | Q96PQ7 | |
| WTLMQDSQDFSSYLS | 181 | Q2TAA2 | |
| MNLYATWEVDRSSSS | 101 | Q6VY07 | |
| EILSNYKDNIQMWSL | 226 | Q9NY74 | |
| DVTVSILTMNNWYNF | 251 | Q8TCU5 | |
| MSWTSSQENYNSTIV | 451 | Q16827 | |
| NILDNMANVTYSTTW | 536 | O75400 | |
| MANVTYSTTWSEAQQ | 541 | O75400 | |
| SEVKDYLWQMLSATQ | 7766 | Q5VST9 | |
| SYWANKQSMLNVTVN | 736 | O15439 | |
| TFQQMWISKQEYDES | 1051 | Q6S8J3 | |
| VMNSTAISLQWNRVY | 836 | O94856 | |
| WKESYYRSTMSQSTQ | 31 | Q9H3D4 | |
| MSSTVSYWILNSTRN | 1 | Q9P2J9 | |
| VALSNESWSMSFAKY | 1326 | Q9Y2I7 | |
| IYEAINILSSMNWDT | 501 | O95876 | |
| TTQNYFGLMSELWDQ | 16 | Q8NCM8 | |
| VSLNEMVNDSWGKQY | 331 | O60741 | |
| ANTTYNIFIMDGKTW | 226 | A0A1B0GVN3 | |
| DSSNLSLWIEYGTMS | 1136 | Q9Y6J0 | |
| AQSEYSWRKMLSGIA | 216 | P13765 | |
| KWTNDYSMVLTGAAI | 611 | Q16394 | |
| STYFSAVKLRWMLDN | 146 | Q14410 | |
| TQEDWNKVLYNGMAS | 921 | O43497 | |
| NKVLYNGMASTSSWA | 926 | O43497 | |
| AAVETTANSLMWILY | 326 | Q07973 | |
| TANSLMWILYNLSRN | 331 | Q07973 | |
| TAMITLNNSVYWQEF | 386 | Q99928 | |
| TPSMKEWQQISSLYT | 251 | Q5R3K3 | |
| IWTEAYMDSKLLSSQ | 486 | Q7Z3S7 | |
| VQTSWNYMNDSLRTD | 216 | Q96S94 | |
| NNISTMSAEWVSKAN | 581 | Q9H2U1 | |
| YSSGQLWKESLANMS | 201 | Q8ND61 | |
| EDWNVVLYNGMASTS | 821 | Q9P0X4 | |
| NSATSTTIAVYWSMN | 3716 | Q8N3K9 | |
| QDVSLNLWNVYSKMD | 206 | Q5TEA3 | |
| WLALDYVASNASVMN | 101 | P11229 | |
| GVMLSQDNITWTARY | 291 | Q96GR2 | |
| WTGVDEAKMQSYSTI | 226 | Q8IZF7 | |
| WSTQNLSMTITRDEY | 1001 | Q9UHN6 | |
| RWKQNGTDIDFTMSY | 61 | Q9UQ52 | |
| SWGMAVNVYSTSITQ | 41 | Q15555 | |
| IETATSFKMYLENWN | 336 | Q6ZNC8 | |
| SFKMYLENWNIQTAT | 341 | Q6ZNC8 | |
| WSSEYSEMQQLSTSN | 946 | O15021 | |
| VMYNAESKGTSAQTW | 661 | Q8IXH8 | |
| LSYSMKDDLWSIQNL | 146 | P05106 | |
| MSIRSSAYSDSWQVD | 6 | P60411 | |
| NNYMIWNLVRKTSSF | 391 | P42892 | |
| WYSNRTLAMNATTLD | 391 | Q16478 | |
| LQNTWVDTMYIANDT | 2221 | Q9UGM3 | |
| TIQSAATYTMWKDVN | 101 | Q96RP9 | |
| SDSERILLSWMNINY | 1746 | Q6ZTR5 | |
| WSYMQQLDSKISANE | 591 | Q8TC92 | |
| MSNVSWENSQTEYSK | 441 | P54277 | |
| TSLSESWYNLLLDMQ | 1041 | Q16531 | |
| NSSADNMLEYKSWLK | 616 | O14830 | |
| NMAGYSTRLKWENTL | 191 | Q8IVI9 | |
| IWSYQMSNKVILTLS | 146 | Q9H720 | |
| QEMVSASEWYLKNLQ | 191 | P32754 | |
| VLSPNMYNSKLWEAS | 451 | A2RTX5 | |
| SSTYWEGKADMETLQ | 281 | P26639 | |
| SSDTSLWVRNIQMYL | 201 | P78382 | |
| LEMYTSASSSRVSWN | 81 | O94941 | |
| NTWALEETSISAYTM | 466 | Q7Z5M5 | |
| LNLEEKTSDWYMNGN | 176 | Q99624 | |
| TAMRTDQYNSRWLND | 241 | Q13275 | |
| MTAYNKGRLQSSFWI | 211 | Q8N7P1 | |
| WASDRKSAMETVLQY | 2076 | O95425 | |
| KLTWTSEEGSYSQDM | 86 | Q8N6T0 | |
| YMNLDIWTTTANRNA | 1581 | A2VDJ0 | |
| RSMWSVNGDSISKIY | 426 | O43426 | |
| SKSWSQSSSLMYTVN | 221 | P12259 | |
| QSQKDYIWSLDATSM | 1796 | A0AVI2 | |
| YSLGMTESQVKVWFQ | 271 | P78426 | |
| DSTIRQWMEYFKASI | 351 | Q6UWF7 | |
| MTFNLYEEWTQVASV | 336 | Q68EM7 | |
| NSLLNAWKEAFGYTM | 246 | Q8TBE7 | |
| SSNYFTAMWTIAKRL | 181 | Q9NYY8 | |
| SIDGSDETKANWMRY | 206 | Q9NQV5 | |
| MNRATVLASSYDTAW | 3156 | Q96Q15 | |
| YSRASLSLWQAMEKG | 1331 | P58107 | |
| SLSTFQQMWISKQEY | 1011 | P0CG39 | |
| VNTMKNSLVSYWNLG | 201 | Q9UJ37 | |
| SFKQTDVYSMALVLW | 441 | P37173 | |
| SLNISWLVNSAAHMY | 231 | Q86SK9 | |
| IETANMSYTNAWALS | 396 | P03915 | |
| TYNKELSMFIVAGWN | 191 | Q8NGP6 | |
| TFQQMWISKQEYDES | 1051 | P0CG38 | |
| VNVTMSTFNWKDYIG | 306 | Q9NY46 | |
| ISWKQYMSGSAVDVS | 3481 | Q9P2P6 | |
| AWSIDLMGQLSSTYS | 146 | Q6P9B9 | |
| MESNWVSLVSKNYEI | 181 | O75934 | |
| SVGLVQSWYMQSFLE | 76 | Q15120 | |
| AIYWSSMEELDQTAQ | 1676 | Q9NRC6 | |
| TVNMTAWTIIYNGTL | 516 | Q08188 | |
| SDVTSFLMEWLSVNY | 86 | Q9H853 | |
| WLALDYVASNASVMN | 106 | P08912 | |
| LSTFQQMWISKQEYD | 351 | P68032 | |
| LMVLSTATNYWTRQQ | 21 | Q8NHS1 | |
| YGSTQQLAEMWLEKN | 771 | Q86X52 | |
| MSETEAWIGLYLNAN | 206 | Q6ZU45 | |
| VSWSMDYVSAKSLQA | 131 | P35523 | |
| SLEVSLELYDWNSMT | 56 | Q8N4M7 | |
| WSLRDTLVSYMQTKE | 5156 | Q63HN8 | |
| IYEVSRAWNMVKSST | 366 | Q4W5G0 | |
| IKQNNSYWRETLQMS | 556 | Q8TF32 | |
| QGWSSAYSIESVIMQ | 311 | Q8WVN8 | |
| IKASNGLWYQMNDSI | 376 | Q9H9J4 | |
| GLWYQMNDSIVSTSD | 381 | Q9H9J4 | |
| NLEFIYNKTGWAMVS | 221 | Q13454 | |
| SSSRFYVVMWKQVTQ | 1031 | P07996 | |
| RTKIQDWQSMYQSTH | 791 | Q12768 | |
| AMTLLTYELRNWSNS | 691 | Q9BX84 | |
| NVYLDMESISNNLWK | 1071 | Q9BX84 | |
| TAVNNMTLKVWNSYT | 441 | Q8WWQ0 | |
| EWGSMQQFLYEISNL | 656 | Q96PV0 | |
| DSMLSSEAAWVSQYK | 451 | Q6NUQ1 | |
| SNWQDALFAYKMSSV | 286 | Q8TB61 | |
| LSQLLEVMSWQFSSY | 491 | Q14765 | |
| NNYWALNLTSMLCLT | 121 | P35270 | |
| TNEMWRSGDSEVYQL | 61 | Q04837 | |
| SYNARLQAMWGQSLL | 3996 | P22105 | |
| QWMTKLDSSDIYNEL | 1031 | P29144 | |
| MDLWSTATYTSSQNR | 226 | Q6UXI7 | |
| TISMAQTQLFAWEAY | 321 | O95391 | |
| ATNEYNTTEDWSLIM | 16 | O75886 | |
| DWVTAAYMDTVSLSA | 1116 | P47989 | |
| MYRQTSGLQATSSWQ | 671 | Q9HCK4 | |
| AAWSTSEISQNALMY | 876 | P08922 | |
| NNWSNDVRASLYSLM | 16 | Q96RJ0 | |
| QAEWSSKTSYQRSMH | 51 | Q9BT92 | |
| TEQYMHSLTWQQALT | 391 | Q9H857 | |
| WSDRNTNMTAKKESY | 781 | Q15149 | |
| LNSYEAEWDMVNTVS | 91 | Q8TC07 | |
| RIVPWMQQESYSSSS | 71 | H0YL09 | |
| TVMSLAGKYTLNNWL | 246 | O96008 | |
| ELWMATKDLSQSSYP | 66 | Q08ER8 | |
| NTYETELSQWEMSDR | 61 | Q8TAQ5 | |
| DTDVQSLQMSIALYW | 1271 | Q01118 | |
| MTQDSWEKLYQQTLR | 356 | Q9UI33 | |
| YKWNGSEIAFLQMSD | 241 | P17014 | |
| WYENLSGLRQQTMAV | 391 | Q9Y210 | |
| KMFTSWDYLIGNSET | 381 | Q8TDI7 | |
| KLMYEVVDNSSNWAV | 1111 | P48553 | |
| ISTDMWRSENQNRAY | 196 | O96006 | |
| WDIKSEQSDLSYMAV | 236 | Q9P2Z0 | |
| MVAGWLTNYSQDSVT | 1 | Q9BR84 | |
| QLDMQSSWVYETGRL | 246 | Q6PJT7 | |
| SMTTISHWLANVKYQ | 936 | Q6ZSZ6 | |
| LEYEMVLTNGKSFWT | 146 | Q8NBT3 | |
| YSFEWQSQVANKTMR | 41 | Q8N9L7 | |
| DVQYLMSAGANISTW | 276 | O14773 | |
| TSGIWMSNQTREYLT | 731 | O75132 | |
| RMLEYFQTTWSVNNG | 506 | Q96L42 | |
| IYWSDLSQRMICSTQ | 441 | P01130 | |
| WSTGMQLRYNISQLE | 1706 | Q9ULV0 | |
| WLMSLNLEQYVSEFS | 996 | Q9ULJ8 | |
| NNAITMNKRLYTEAW | 2956 | P20929 |